Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.091 | 0.6 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.096 | 0.6 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |